Report overview
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Treatment Drugs. This report contains market size and forecasts of Erectile Dysfunction Treatment Drugs in global, including the following market information:
Global Erectile Dysfunction Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Erectile Dysfunction Treatment Drugs market was valued at US$ 4995.6 million in 2022 and is projected to reach US$ 6356.9 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
We surveyed the Erectile Dysfunction Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erectile Dysfunction Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Phosphodiesterase Type 5 Inhibitors
Prostaglandin E1
Global Erectile Dysfunction Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinic
Others
Global Erectile Dysfunction Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erectile Dysfunction Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Erectile Dysfunction Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Dong-A Pharmaceutical Co. Ltd
Vivus, Inc.
Meda Pharmaceuticals
Bayer AG
Johnson & Johnson Services
Apricus Biosciences
Eli Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Erectile Dysfunction Treatment Drugs, market overview.
Chapter 2: Global Erectile Dysfunction Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Erectile Dysfunction Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Erectile Dysfunction Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
